Generic vancomycin products: Analysis of serum concentrations in patients with acute myeloid leukemia.
Fiche publication
Date publication
mai 2014
Journal
Annales pharmaceutiques francaises
Auteurs
Membres identifiés du Cancéropôle Est :
Dr CAILLOT Denis, Dr FAGNONI Philippe, Dr GUIGNARD Marie-Hélène, Dr SGRO Catherine, Dr CHRETIEN Marie-Lorraine
Tous les auteurs :
Monnier A, Malbranche C, Fagnoni P, Serge Aho L, Guerard P, Sgro C, Guignard MH, Croisier-Bertin D, Chavanet P, Chrétien ML, Caillot D, Boulin M
Lien Pubmed
Résumé
Concerns have recently emerged about the quality of generic vancomycin products. Our aim is to analyze serum vancomycin concentrations measured 48 hours after the start of an empirical treatment regimen in patients with acute myeloid leukemia (AML) who received one of the two generic vancomycin products available in France.
Mots clés
Adolescent, Adult, Aged, Anti-Bacterial Agents, blood, Drugs, Generic, Female, Humans, Kidney, metabolism, Leukemia, Myeloid, Acute, metabolism, Male, Middle Aged, Retrospective Studies, Vancomycin, blood, Young Adult
Référence
Ann Pharm Fr. 2014 May;72(3):178-83